Control of asthma with triamcinolone acetonide aerosol inhalations at 12-hour intervals.
D000293:Adolescent; D000328:Adult; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005540:Forced Expiratory Flow Rates; D006801:Humans; D008297:Male; D008450:Maximal Midexpiratory Flow Rate; D008875:Middle Aged; D012129:Respiratory Function Tests; D012138:Respiratory Therapy; D013147:Spirometry; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014797:Vital Capacity
D000336:Aerosols; D014222:Triamcinolone Acetonide